Spire Wealth Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $15.3K | Sell |
|
|||||
|
2025
Q2 | $14.8K | Sell |
|
|||||
|
2025
Q1 | $21.5K | Sell |
|
|||||
|
2024
Q4 | $26.8K | Sell |
|
|||||
|
2024
Q3 | $22.8K | Hold |
|
|||||
|
2024
Q2 | $27.3K | Buy |
|
|||||
|
2024
Q1 | $18.8K | Sell |
|
|||||
|
2023
Q4 | $21K | Buy |
|
|||||
|
2023
Q3 | $8.21K | Sell |
|
|||||
|
2023
Q2 | $36.7K | Buy |
|
|||||
|
2023
Q1 | $38.4K | Buy |
|
|||||
|
2022
Q4 | $15K | Buy |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $11K | Buy |
|
|||||
|
2022
Q1 | $10K | Sell |
|
|||||
|
2021
Q4 | $11K | Sell |
|
|||||
|
2021
Q3 | $30K | Hold |
|
|||||
|
2021
Q2 | $30K | Sell |
|
|||||
|
2021
Q1 | $58K | Buy |
|